Evaluation of liver parenchymal blood flow with contrast-enhanced US: Preliminary results in healthy and cirrhotic patients

Academic Radiology

Volumn 10, Issue 8, 2003, Pages 869-876

  Gasparini, Cristiana ^a   Bertolotto, Michele ^a   Crocè, Saveria Lory ^b   Perrone, Rosaria ^a   Quaia, Emilio ^a   Tiribelli, Claudio ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b NONE

Author keywords

Contrast enhanced ultrasound; Liver cirrhosis; Liver hemodynamics; Microbubble contrast agents

Indexed keywords

SHU 508;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INFUSION; ECHOGRAPHY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; IMAGE ANALYSIS; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER PARENCHYMA; MALE; PRIORITY JOURNAL; SIGNAL PROCESSING;

EID: 0043028666     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)00003-5     Document Type: Article

References (23)

1. Zoli M, Magalotti D, Bianchi G, et al. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J Hepatol 1997; 23:129-134.
2. Colli A, Cocciolo M, Riva C, et al. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: correlation with histologic findings. AJR 1994; 162:833-837.
3. Iwao T, Toyonaga A, Shigemori H, et al. Hepatic artery hemodynamic responsiveness to altered portal blood flow in normal and cirrhotic livers. Radiology 1996; 200:793-798.
4. Piscaglia F, Gaiani S, Zironi G, et al. Intra- and extrahepatic arterial resistances in chronic hepatitis and liver cirrhosis. Ultrasound Med Biol 1997; 23:675-682.
5. Burns P, Taylor K, Blei AT. Doppler flowmetry and portal hypertension. Gastroenterology 1987; 92:824-826.
6. Vilgrain V, Lebrec D, Menu Y, et al. Comparison between ultrasonographic signs and degree of portal hypertension in patients with cirrhosis Gastrointest Radiol 1990; 15:218-222.
7. Blomley MJK, Albrecht T, Cosgrove DO, et al. Liver vascolar transit time analized with dynamic hepatic venography with bolus injection of a US contrast agent: early experience in 7 patients with metastases. Radiology 1998; 209:862-866.
8. Albrecht T, Bomley MJK, Cosgrove DO, et al. Non invasive diagnosis of hepatic cirrhosis by transit time analysis of an ultrasound contrast agent. Lancet 1999; 353(9164):1579-1583.
9. Blomley MJK, Cosgrove DO, Taylor-Robinson SD, et al. Transit-time studies with Levovist in patients with and without hepatic cirrhosis: A promising new diagnostic tool. Eur Radiol 1999; 9:S377-S381.
10. Bauer A, Schlief R, Zomack M, et al. Acoustically stimulated microbubbles in diagnostic ultrasound: properties and implications for diagnostic use. In: Nanda NC, Schlief R, Goldberg BB, eds. Advances in echo imaging using contrast enhancement. Dubai: Kluwer, 1997; 669-684.
11. Blomley MKJ, Jayaram V, Cosgrove DO, et al. Linear dose response relationship with the US contrast agent BR1: a quantitative study in normal volunteers. Eur Radiol 1997; 7:S69.
12. Albrecht T, Urbank A, Mahler M, et al. Prolongation and optimization of Doppler enhancement with the ultrasound contrast agent Levovist by continuous infusion: preliminary experience. Radiology 1998; 207: 339-347.
13. Kaul S. Myocardial contrast echocardiography. 15 years of research and development. Circulation 1997; 96:3745-3760.
14. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97:473-483.
15. Wei K, Le E, Bin JP, Coggins M, et al. Quantification of renal blood flow with contrast-enhaced ultrasound. J Am Coll Cardiol 2001; 37: 1135-1140.
16. Wei K, Ragosta M, Thorpe J, et al. Noninvasive Quantification of Coronary Blood Flow Reserve in Humans Using Myocardial Contrast Echocardiography. Circulation 2001; 103:2560-2565.
17. Blomley M, Albrecht T, Cosgrove D, et al. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998; 351(9102):568.
18. Blomley M, Albrecht T, Cosgrove D, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SHU 508A: early experience. Radiology 1999; 210:409-416.
19. Harvey CJ, Blomley MJK, Eckersley RJ, Cosgrove DO. Developments in ultrasound contrast media. Eur Radiol 2001; 11:675-689.
20. Kim TK, Choi BI, Hong HS, et al. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SHU 508A: preliminary study. Ultrasound Med Biol 2000; 26: 1439-1444.
21. Wei K, Skiba D, Firschke C, et al. Interaction between microbubbles and ultrasound: in vitro and vivo observations. J Am Coll Cardiol 1997; 29:1081-1088.
22. nd ed. New York, NY: Raven Press, 1988; 683-704.
23. th Heart Centre European Symposium on Ultrasound Contrast Imaging, 2000